A Case of Crohn’s Disease with Improvement after Azathioprine-Induced Pancytopenia
The immunosuppressant azathioprine (AZA) is widely used in the treatment of inflammatory bowel disease (IBD) for both inducing and maintaining remission. However, the adverse effects of AZA can often necessitate a dose reduction or discontinuation. Bone marrow suppression is one of the most serious...
Main Authors: | Yong Sung Choi, Jung Pil Suh, Kee Ho Song, Jae Bum Lee, Doo Seok Lee, In Taek Lee, Do Sun Kim, Doo Han Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2011-07-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/329707 |
Similar Items
-
Azathioprine induced pancytopenia: A serious complication
by: Hadda V, et al.
Published: (2009-01-01) -
An Acute Brucellosis Case Presented with Pancytopenia and Hepatitis
by: Heval Bilek, et al.
Published: (2018-03-01) -
Pregnancy with pancytopenia: An Observational Study
by: H S Sridevi
Published: (2020-01-01) -
Pancytopenia revealing acute brucellosis
by: Yassine Ben Lahlou, et al.
Published: (2021-01-01) -
Lymphomatoid Granulomatosis with Splenomegaly and Pancytopenia
by: Mohammad Bagher OWLIA, et al.
Published: (2010-01-01)